ABBV vs AZN: Fair Value Comparison

AbbVie Inc vs. AstraZeneca PLC · General Drug Manufacturers

ABBV's model fair value sits 18.9% below its current price; AZN's model fair value sits 7.1% above its current price. Of the two, AZN trades further below its model estimate. Model estimates under stated assumptions. Data as of 2026-10-22.

ABBVAZN
Price$285.44$172.63
Model fair value (multi-method blend)$231.45$184.89
Model fair value differential-18.9%+7.1%
Methods with a model value above price5 of 87 of 10
Fundamental strengthA-A-
Next earnings report2026-10-302026-10-30

Differential = model fair value versus the current price; positive means the price sits below the model estimate.

More comparisons

LLY vs ABBV · JNJ vs ABBV · ABBV vs MRK · ABBV vs NVS · LLY vs AZN · JNJ vs AZN · MRK vs AZN · NVS vs AZN · All General Drug Manufacturers stocks · Compare any two stocks